Abstract
Objective: To describe clinical and epidemiological characteristics of patients with Disorders of Sexual Development (DSD). Methods: This was a descriptive and retrospective analysis of medical records of 167 patients with DSD from a specialized outpatient clinic in Salvador, Bahia, Brazil. Sociodemographic and clinical data were collected and analyzed using descriptive statistics using Microsoft Excel 365. The study was approved by the Research Ethics Committee. Results: The most common diagnoses were Turner syndrome (33.53%) and Congenital Adrenal Hyperplasia (32.34%). The most frequent reasons for referral to the service were atypical genitalia (23.35%) and pubertal delay (14.37%). The mean age at diagnosis was 7.82 years. Family history of DSD was reported by 10.78% of patients. Three patients (1.8%) underwent gender reassignment, all with Congenital Adrenal Hyperplasia. 32.93% of patients had sex chromosome DSD karyotypes, 28.74% 46, XX and 26.95% 46, XY. Low Bone Mineral Density, obesity and hypothyroidism were the most common comorbidities. Eighteen patients (10.78%) underwent gonadectomy and 30 (18%) underwent vaginoplasty and/or clitoroplasty. Conclusion: Comparison of these data with those of similar studies revealed similarities, such as main etiologies, reasons for referral and tendency for early diagnosis, and differences that may be related to regional particularities.
References
ABDULLAH MA, et al. Disorders of sex development among Sudanese children: 5-year experience of a pediatric endocrinology clinic. Journal of Pediatric Endocrinology and Metabolism, 2012; 25(11–12): 1065–1072.
ALIZAI NK, et al. Feminizing genitoplasty for congenital adrenal hyperplasia: What happens at puberty? Journal of Urology, 1999; 161(5): 1588–1591.
ANDRADE JGR, et al. Perfil clínico de 62 casos de distúrbios da diferenciação sexual. Revista Paulista de Pediatria, 2008; 26(4): 321–328.
AUGOULEA A, et al. Turner syndrome and osteoporosis. Maturitas, 2019; 130: 41–49.
AZZIZ R, et al. Congenital adrenal hyperplasia: Long-term results following vaginal reconstruction. Fertility and Sterility, 1986; 46(6): 1011–1014.
BECK MSEL, et al. Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service. Jornal de Pediatria, 2029; 96(5): 607–613.
COOLS M, et al. Caring for individuals with a difference of sex development (DSD): A Consensus Statement. Nature Reviews Endocrinology, 2018; 14(7): 415–429.
COOLS M e KÖHLER B. Disorders of sex development. Brook’s Clinical Pediatric Endocrinology, 2019; 105–131.
COX K, et al. Novel associations in disorders of sex development: Findings from the I-DSD registry. Journal of Clinical Endocrinology and Metabolism, 2014; 99(2): 348–355.
DONAHOE PK e GUSTAFSON ML. Early one-stage surgical reconstruction of the extremely high vagina in patients with congenital adrenal hyperplasia. Journal of Pediatric Surgery, 1994; 29(2): 352–358.
ERDOAN S, et al. Etiological classification and clinical assessment of children and adolescents with disorders of sex development. JCRPE Journal of Clinical Research in Pediatric Endocrinology, 2011; 3(2): 77–83.
FARKAS A e CHERTIN B. Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia. Journal of Pediatric Endocrinology and Metabolism, 2001; 14(6): 713–722.
GANIE Y, et al. Disorders of sex development in children in KwaZulu-Natal Durban South Africa: 20-year experience in a tertiary centre. Journal of Pediatric Endocrinology and Metabolism, 2017; 30(1): 11–18.
JARURATANASIRIKUL S e ENGCHAUN V. Management of children with disorders of sex development: 20-Year experience in southern Thailand. World Journal of Pediatrics, 2014; 10(2): 168–174.
KOHVA E, et al. Disorders of sex development: Timing of diagnosis and management in a single large tertiary center. Endocrine Connections, 2018; 7(4): 595–603.
MEYER-BAHLBURG HFL. Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 2001; 30(1): 155–171.
NIESCHLAG E. Klinefelter syndrome. Deutsches Arzteblatt International, 2013; 110(20): 347–353.
PASTERSKI V, et al. Impact of the consensus statement and the new DSD classification system. Best Practice and Research: Clinical Endocrinology and Metabolism, 2010; 24(2): 187–195.
PODGÓRSKI R, et al. Congenital adrenal hyperplasia: Clinical symptoms and diagnostic methods. Acta Biochimica Polonica, 2018; 65(1): 25–33.
POWELL DM, et al. A proposed classification of vaginal anomalies and their surgical correction. Journal of Pediatric Surgery, 1995; 30(2): 271–276.
REY RA e GRINSPON RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Practice and Research: Clinical Endocrinology and Metabolism, 2011; 25(2): 221–238.
RÖHLE R, et al. Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: Design, methodology, recruitment, data quality and study population. BMC Endocrine Disorders, 2017; 17(1): 1–26.
SCHOBER JM. Feminizing genitoplasty: A synopsis of issues relating to genital surgery in intersex individuals. Journal of Pediatric Endocrinology and Metabolism, 2004; 17(5): 697–703.
SILVA MRD. Revendo os estigmas tiroidianos na Síndrome de Turner. Arquivos Brasileiros de Endocrinologia & Metabologia, 2007; 51(3): 371–372.
WALIA R, et al. Disorders of sex development: A study of 194 cases. Endocrine Connections, 2018; 7(2): 364–371.
WISNIEWSKI AB, et al. Management of 46, XY Differences/Disorders of Sex Development (DSD) throughout Life. Endocrine Reviews, 2019; 40(6): 1547–1572.
